Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Neo-Bladder construct augmentation cystoplasty in spina bifida-associated neurogenic bladder
2007-006433-13Phase 2Terminated
- Sponsor
- Tengion, Inc.
- Start
- Mar 2008
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of autologous neobladder construct in neurogenic bladder and spina bifida (SB), sponsored by Tengion, Inc. Primary endpoint: Percent change from baseline in bladder compliance. Started Mar 2008; status: terminated.
02
Drugs
autologous neobladder construct
03
Conditions
neurogenic bladderspina bifida (SB)
Beyond the preview
Go deeper on 2007-006433-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006433-13.